Swedish AI Researcher Simon Olsson Awarded ERC Consolidator Grant for Protein Modeling

Simon Olsson's AI-driven protein modeling research receives major ERC Consolidator Grant, advancing drug development innovation.

    Key details

  • • Simon Olsson awarded ERC Consolidator Grant in 2025 for AI research on proteins.
  • • Research combines AI with scientific principles to accelerate molecular simulations and drug design.
  • • Work is part of AIMLeNS group focusing on molecular science using advanced AI.
  • • ERC Consolidator Grant supports researchers with 7 to 12 years post-doctoral experience and strong scientific track records.

Simon Olsson, a researcher at Chalmers University, has been awarded the prestigious ERC Consolidator Grant in 2025 for his pioneering AI research on protein modeling and molecular design. His work, conducted within the AIMLeNS group (Artificial Intelligence and Machine Learning in the Natural Sciences), focuses on combining advanced AI techniques with fundamental scientific principles to explore chemical and biological domains beyond traditional computational methods and experiments. This approach significantly accelerates molecular simulations and facilitates the design of new molecules, including drug candidates and biological therapies. The grant recognizes Olsson's proven track record and provides crucial support for his team to achieve critical scientific goals related to faster drug development, material creation, and biomolecule design. ERC grants honor projects addressing major scientific questions and are aimed at researchers with 7 to 12 years of post-doctoral experience. Olsson’s award highlights Sweden's cutting-edge contributions to AI-driven drug development research.

This article was synthesized and translated from native language sources to provide English-speaking readers with local perspectives.

The top news stories in Sweden

Delivered straight to your inbox each morning.